:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Glucagon-like peptide-1 receptor agonists: A new option for weight management
Frankel SR, Scheinberg DA, Miller, Jr, WH, Dmitrovsky E, Jakubowski A, Gabrilove J, Tafuri A, Andreeff M , Jhanvar S, Gordon M, Warrell Jr D
By comparing -MSH with its analogs, we see how structural changes in peptides can modify receptor selectivity, potency, and therapeutic potential
:format(webp))
4 hours | Primary site of action: vascular signaling pathways, NO system | Key receptors: VEGFR2, eNOS | Research focus: gastrointestinal, tendons, inflammation | Endogenous: no (synthetic, derived from gastric juice) | Gene modulation: limited documentation TB-500 Half-life: approx
Do not place the refrigerator near heat sources
US$ 27.14
US$ 23.45
US$ 23.44
US$ 27.43
US$ 22.68
US$ 27.12
US$ 21.39
US$ 24.96
